Tablet Press with Fastest-in-Class Changeover - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Tablet Press with Fastest-in-Class Changeover


At INTERPHEX Fette Compacting America will showcase the FE35 Tablet Press, which offers unprecedented productivity and flexibility, and best-in-class changeover time. The single-rotary tablet press can be fitted with up to 51 stations to produce up to 367,000 tablets/hr. The FE35 is clad in easily-detachable, FDA certified polymer panels, and offers 360-degree access. All product contact parts are stainless steel.

Fette Compacting America, Rockaway, NJ
www.fette-compacting.com • tel. 973.586.8722
INTERPHEX Booth # 2505C

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
29%
Oversee medical treatment of patients in the US.
11%
Provide treatment for patients globally.
7%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics

Click here